Steven Lister

Predicting atrial fibrillation in primary care using machine learning

Nathan R. Hill, Daniel Ayoubkhani, Phil McEwan et al. · PLoS ONE · 2019 · 145 citations · Full text

Computing, Cardiology, Computer Science +17

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

M. Charokopou, Phil McEwan, Steven Lister et al. · BMC Health Services Research · 2015 · 41 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm

Nathan R. Hill, Belinda Sandler, Ruth Mokgokong et al. · Journal of Medical Economics · 2019 · 37 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus

M. Charokopou, Phil McEwan, Steven Lister et al. · Diabetic Medicine · 2015 · 35 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Sex Differences in Oral Anticoagulation Therapy in Patients Hospitalized With Atrial Fibrillation: A Nationwide Cohort Study

Kuan Ken Lee, Dimitrios Doudesis, Rong Bing et al. · Journal of the American Heart Association · 2023 · 27 citations · Full text

Medicine, Cardiology, Pharmacology +15